Dr. Michael Christopher Lubrano, MD, MPH

Dr. Lubrano practices at South Shore Hospital in South Weymouth, Massachusetts, part of South Shore Health System.

Dr. Lubrano's NPI, 1003229279, was assigned on June 5, 2014. Dr. Lubrano graduated from Albert Einstein College of Medicine of Yeshiva University in 2014. Dr. Lubrano holds Massachusetts license 274724.

Dr. Lubrano's primary practice is South Shore Hospital, at 55 Fogg Road, South Weymouth, MA 02190 in Norfolk County. The practice phone is (781) 340-8000.

Dr. Lubrano's primary practice is South Shore Hospital in South Weymouth, Massachusetts, part of South Shore Health System. Dr. Lubrano is also affiliated with Brigham and Women's Hospital. The medical group on file is Brigham and Women's Hospital. Dmand AI also links Dr. Lubrano to 5 more hospitals and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lubrano practices, 7 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Lubrano's primary specialty in the NPI Registry, under taxonomy code 207LP2900X. Dr. Lubrano is board certified in anesthesiology by the American Board of Anesthesiology. Dr. Lubrano is licensed in Massachusetts.

CMS data shows 681 Medicare services from Dr. Lubrano across 14 procedure codes in 2024, for 345 Medicare patients. Medicare paid $53,462 for them.

CMS counts 345 Medicare patients who saw Dr. Lubrano in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have arthritis, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lubrano's median patient age at 73, with 57% women.

In 2024, Dr. Lubrano wrote 359 Medicare Part D claims for 112 patients. 96% of them were for generic drugs. CMS names the drug for 239 of them, across 6 drugs with 11 or more claims each, at $2,315 in total drug cost. In 2023, CMS named 62 claims across 3 drugs.

Dr. Lubrano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lubrano as offering telehealth.

CMS Open Payments shows 51 general payments to Dr. Lubrano from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 88% of the total. Medtronic USA, Inc. paid the most, $1,116.

Dr. Lubrano graduated from Albert Einstein College of Medicine of Yeshiva University in 2014.